Boston Scientific Corporation BSX has commenced a global, multi-center UNTOUCHED trial to evaluate the clinical efficiency of its Emblem Subcutaneous Implantable Defibrillator (S-ICD) System. This ...

The Subcutaneous Implantable Cardioverter‑Defibrillator System Post Approval Study (S‑ICD PAS), which observed patients with subcutaneous implantable cardioverter-defibrillators (S‑ICDs) for 5 years, ...

The overall primary composite endpoint of inappropriate shocks and complications came out nearly identical (HR 0.99, 95% CI 0.71-1.39, P=0.01 for noninferiority) over a median 4 years in the ...

Boston Scientific ($BSX) played up a data registry study in the Journal of the American College of Cardiology demonstrating the safety of its subcutaneous implantable ...

MARLBOROUGH, Boston Scientific has initiated a worldwide study to evaluate the rate and causes of shocks for patients implanted with the EMBLEM™ Subcutaneous Implantable Defibrillator (S-ICD) for ...

Please provide your email address to receive an email when new articles are posted on . Among patients who received implantable cardioverter defibrillator therapy, a subcutaneous vs. transvenous ...

MARLBOROUGH, Mass., Nov. 8, 2017 /PRNewswire/ -- Updated guidelines issued by the American Heart Association (AHA), the American College of Cardiology (ACC) and the Heart Rhythm Society (HRS) now ...

Please provide your email address to receive an email when new articles are posted on . Among patients who received implantable cardioverter defibrillator therapy, the subcutaneous or transvenous ...

The study, "Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-year Results from a Pooled Analysis of the IDE Study and EFFORTLESS Registry" was led by Dr. Martin Burke, ...

(RTTNews) - Boston Scientific (BSX) reported the final results from the UNTOUCHED study of the EMBLEM Subcutaneous Implantable Defibrillator, or S-ICD, System, an approved implantable defibrillator ...

The Boston Scientific Corporation (NYSE:BSX) S-ICD® (subcutaneous implantable defibrillator) System showed a significant reduction in major lead-related complications when compared with both single ...